1. Stocks
    2. /
  2. Moderna (NASDAQ: MRNA)
    3. /

Moderna (NASDAQ: MRNA) Share Price and News

$36.85 $-2.92 (-7.3%) Saturday, 16 November 2024 at 8:00:00 am Australian Eastern Daylight Time

Moderna Chart and Price Data

About Moderna

Last updated 16-11-2024, 08:00:00am AEDT
Current Price $36.85
Change $-2.92 (-7.3%)
Close Price $36.85
Open Price $38.55
Bid $37.15
Ask $37.29
Day Range $35.80 - $38.70
Year Range $35.80 - $170.47
Volume 24,355,514
Average Volume 6,130,754
Market Cap $14,180,543,300.00
Earnings Per Share $-5.82

    • Moderna (NASDAQ: MRNA)
    Latest News

    share price gaining
    ETFs

    What were the biggest movers on the Nasdaq 100 (ASX:NDQ) overnight?

    | Marc Sidarous

    What might be affecting your NASDAQ ETF in today's trading?

    Read more »

    four excited doctors with their hands in the air
    ETFs

    Expert reveals top pandemic ETF play – up 58% in 12 months

    | Bernd Struben

    COVID variants are likely to drive longer-term demand for mRNA vaccines.

    Read more »

    School boy wearing glasses standing in front of chalk board with maths and share price calculations on it
    ⏸️ ASX Shares

    Will the ASX 200 follow the S&P 500 to double its March 2020 lows?

    | Bernd Struben

    The Aussie market often follows US markets higher or lower.

    Read more »

    A happy doctor in a white coat dancing due to his excitement over the EBOS acquisition
    Healthcare Shares

    Why the IDT (ASX:IDT) share price is rocketing 25% on Wednesday

    | Marc Sidarous

    The company claims it can make 100 million doses of mRNA vaccine within 18 months.

    Read more »

    US economy and sharemarket with piggy bank
    Share Market News

    ASX investors were buying Robinhood, Square shares last week

    | Sebastian Bowen

    ASX investors were buying Robinhood and Square shares last week

    Read more »

    man receiving covid 19 vaccine moderna biontech
    International Stock News

    Better biotech stock: Moderna vs. BioNTech

    | Jason Hawthorne

    The two companies behind the gene-based COVID vaccines are a lot different than you might think.

    Read more »

    Female patient receives Pfizer covid vaccine administered by female doctor
    Coronavirus News

    TGA approves Pfizer vaccine for kids aged 12-15 years old

    | Marc Sidarous

    The Therapeutics Goods Administration decided to approve the vaccine for kids late last night.

    Read more »

    nurse giving a vaccination to a male patient
    International Stock News

    Why Moderna topped the market on Thursday

    | Eric Volkman

    The company keeps scoring new supply deals across the Pacific.

    Read more »

    share price soaring
    International Stock News

    Here's why Moderna stock soared 125% during the first 6 months of 2021

    | James Brumley

    The COVID-19 vaccine maker has been well rewarded for coming up with a stopgap solution as quickly as it did.

    Read more »

    A stressed woman with her head in her hands sits at her desk reading about falling ASX 200 mining shares on her laptop
    International Stock News

    Does This Shocking CDC Statement Mean Trouble for Pfizer and Moderna?

    | Adria Cimino

    It has to do with the companies' next step in the coronavirus vaccine rollout.

    Read more »

    health care worker giving a woman a COVID 19 vaccine
    International Stock News

    With COVID-19 variant threats rising, why are vaccine stocks falling?

    | Dan Caplinger

    Stock markets moved slightly higher despite general worries.

    Read more »

    woman preparing Moderna vaccine
    International Stock News

    Why Moderna shares surged 27% in June

    | Billy Duberstein

    Growing concern over the emerging delta variant and more long-term supply agreements boosted the stock last month.

    Read more »

    Profile

    since

    Note